Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 19 studies | 26% ± 10% | |
| microglial cell | 11 studies | 29% ± 12% | |
| astrocyte | 10 studies | 29% ± 17% | |
| oligodendrocyte precursor cell | 9 studies | 28% ± 13% | |
| fibroblast | 8 studies | 22% ± 5% | |
| oligodendrocyte | 8 studies | 31% ± 11% | |
| macrophage | 7 studies | 28% ± 6% | |
| epithelial cell | 7 studies | 37% ± 16% | |
| GABAergic neuron | 7 studies | 34% ± 18% | |
| ciliated cell | 6 studies | 27% ± 8% | |
| pericyte | 6 studies | 19% ± 4% | |
| adipocyte | 5 studies | 22% ± 3% | |
| glutamatergic neuron | 5 studies | 46% ± 22% | |
| retinal rod cell | 4 studies | 26% ± 5% | |
| goblet cell | 4 studies | 33% ± 21% | |
| club cell | 4 studies | 19% ± 6% | |
| endothelial cell of lymphatic vessel | 4 studies | 26% ± 2% | |
| interneuron | 4 studies | 43% ± 23% | |
| neuron | 4 studies | 36% ± 15% | |
| glial cell | 3 studies | 18% ± 3% | |
| capillary endothelial cell | 3 studies | 21% ± 2% | |
| myeloid cell | 3 studies | 18% ± 3% | |
| type I pneumocyte | 3 studies | 19% ± 4% | |
| type II pneumocyte | 3 studies | 19% ± 4% | |
| dendritic cell | 3 studies | 16% ± 0% | |
| basal cell | 3 studies | 42% ± 9% | |
| smooth muscle cell | 3 studies | 20% ± 1% | |
| mast cell | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1893.08 | 1445 / 1445 | 100% | 32.06 | 183 / 183 |
| ovary | 100% | 1689.95 | 180 / 180 | 100% | 23.95 | 430 / 430 |
| prostate | 100% | 2142.26 | 245 / 245 | 100% | 43.63 | 502 / 502 |
| breast | 100% | 2093.96 | 459 / 459 | 100% | 49.07 | 1116 / 1118 |
| lung | 100% | 1664.11 | 576 / 578 | 100% | 32.80 | 1153 / 1155 |
| intestine | 100% | 2246.84 | 966 / 966 | 99% | 40.84 | 524 / 527 |
| brain | 100% | 966.99 | 2634 / 2642 | 100% | 27.49 | 703 / 705 |
| thymus | 100% | 1909.79 | 653 / 653 | 99% | 36.39 | 601 / 605 |
| kidney | 100% | 1752.55 | 89 / 89 | 99% | 29.19 | 893 / 901 |
| bladder | 100% | 2115.33 | 21 / 21 | 99% | 35.85 | 499 / 504 |
| stomach | 100% | 1566.85 | 359 / 359 | 99% | 35.77 | 283 / 286 |
| uterus | 100% | 2222.70 | 170 / 170 | 99% | 30.29 | 454 / 459 |
| adrenal gland | 100% | 1541.74 | 258 / 258 | 99% | 25.30 | 227 / 230 |
| pancreas | 99% | 804.72 | 324 / 328 | 98% | 38.80 | 175 / 178 |
| skin | 100% | 2198.79 | 1809 / 1809 | 95% | 33.44 | 450 / 472 |
| liver | 100% | 960.06 | 226 / 226 | 92% | 14.26 | 374 / 406 |
| blood vessel | 100% | 2000.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1703.53 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 28.29 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 29.75 | 1 / 1 |
| adipose | 100% | 1977.31 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 802.10 | 843 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 16.68 | 28 / 29 |
| muscle | 94% | 568.49 | 758 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 90% | 16.66 | 72 / 80 |
| peripheral blood | 81% | 735.12 | 754 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_1905280 | Biological process | negative regulation of retrograde transport, endosome to Golgi |
| GO_0050708 | Biological process | regulation of protein secretion |
| GO_0034315 | Biological process | regulation of Arp2/3 complex-mediated actin nucleation |
| GO_0032588 | Cellular component | trans-Golgi network membrane |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
| GO_0005543 | Molecular function | phospholipid binding |
| Gene name | ARFIP1 |
| Protein name | ADP-ribosylation factor interacting protein 1 (Arfaptin 1), isoform CRA_b (ARFIP1 protein) (cDNA FLJ53696, highly similar to Arfaptin-1) Arfaptin-1 (ADP-ribosylation factor-interacting protein 1) |
| Synonyms | hCG_26981 |
| Description | FUNCTION: Plays a role in controlling biogenesis of secretory granules at the trans-Golgi network . Mechanistically, binds ARF-GTP at the neck of a growing secretory granule precursor and forms a protective scaffold . Once the granule precursor has been completely loaded, active PRKD1 phosphorylates ARFIP1 and releases it from ARFs . In turn, ARFs induce fission . Through this mechanism, ensures proper secretory granule formation at the Golgi of pancreatic beta cells . . |
| Accessions | ENST00000451320.6 [P53367-1] ENST00000356064.3 [P53367-2] ENST00000429148.6 [P53367-3] ENST00000405727.6 [P53367-2] P53367 ENST00000353617.7 [P53367-1] B4E273 |